1. Home
  2. HOPE vs OGN Comparison

HOPE vs OGN Comparison

Compare HOPE & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hope Bancorp Inc.

HOPE

Hope Bancorp Inc.

HOLD

Current Price

$11.59

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.35

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOPE
OGN
Founded
1986
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
HOPE
OGN
Price
$11.59
$6.35
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
$13.75
$11.75
AVG Volume (30 Days)
801.7K
3.1M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
4.82%
1.26%
EPS Growth
N/A
N/A
EPS
0.49
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$38.10
$0.42
Revenue Next Year
$10.98
$1.67
P/E Ratio
$23.73
$8.83
Revenue Growth
N/A
N/A
52 Week Low
$8.83
$5.69
52 Week High
$12.79
$13.28

Technical Indicators

Market Signals
Indicator
HOPE
OGN
Relative Strength Index (RSI) 60.51 46.64
Support Level $10.68 $6.18
Resistance Level $11.71 $7.87
Average True Range (ATR) 0.26 0.26
MACD 0.11 0.06
Stochastic Oscillator 85.14 79.76

Price Performance

Historical Comparison
HOPE
OGN

About HOPE Hope Bancorp Inc.

Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services, and other banking services.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: